Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Leukemia inhibitory factor regulates microvessel density by modulating oxygen-dependent VEGF expression in mice
Yoshiaki Kubota, Masanori Hirashima, Kazuo Kishi, Colin L. Stewart, Toshio Suda
Yoshiaki Kubota, Masanori Hirashima, Kazuo Kishi, Colin L. Stewart, Toshio Suda
View: Text | PDF
Research Article Vascular biology

Leukemia inhibitory factor regulates microvessel density by modulating oxygen-dependent VEGF expression in mice

  • Text
  • PDF
Abstract

To meet tissue requirements for oxygen, capillaries must be properly distributed without excess or shortage. In this process, tissue oxygen concentration is well known to determine capillary density via the hypoxia-induced cascade, in which HIFs and VEGF play key roles. However, some additional mechanisms modulating this cascade are suggested to be involved in precise capillary network formation. Here, we showed that leukemia inhibitory factor (LIF) was predominantly expressed in developing endothelium, while its receptor was expressed in surrounding cells such as retinal astrocytes. The retinas of Lif–/– mice displayed increased microvessel density accompanied by sustained tip cell activity, due to increased VEGF expression by astrocytes in the vascularized area. Lif–/– mice resisted hyperoxygen insult in the oxygen-induced retinopathy model, whereas they paradoxically had increased numbers of neovascular tufts. In an in vitro study, LIF inhibited hypoxia-induced VEGF expression and proliferation in cultured astrocytes. Lif–/– mice also exhibited similarly increased microvessel density and upregulated VEGF in various tissues outside the retina. Together, these findings suggest that tissues and advancing vasculature communicate to ensure adequate vascularization using LIF as well as oxygen, which suggests a new strategy for antiangiogenic therapy in human diseases such as diabetic retinopathy and cancer.

Authors

Yoshiaki Kubota, Masanori Hirashima, Kazuo Kishi, Colin L. Stewart, Toshio Suda

×

Figure 3

Lif–/– mice show increased proliferation in endothelial cells and astrocytes.

Options: View larger image (or click on image) Download as PowerPoint

Lif–/– mice show increased proliferation in endothelial cells and astro...
(A–L) Triple IHC for PECAM-1, PDGFRα, and pax-2. Note the densely condensed astrocyte network (asterisks) in the hypervascularized area (arrowheads) of Lif–/– mice at P0.5 and P4. (M and N) Transition of vascular density (M) or the number of astrocytes identified as pax-2+ nuclei in vascularized area (N). Data are means of 4–8 random FOV in the vascularized area per retina (n = 5). (O and P) BrdU incorporation assay combined with triple IHC for PECAM-1, PDGFRα, and DAPI in P4 retinas. Note the BrdU+ astrocytes (asterisks) and endothelial cells (black dots) in the Lif–/– retina. (Q) Quantification of BrdU+ astrocytes and endothelial cells. Data are means from 8 random FOV around the sprouting edge per retina (n = 7). (R and S) IHC for neurofilament on P4 retinas. (T) Quantitative PCR of pdgfa for isolated RNA from P4 retinas (n = 5). (U and V) Confocal images of FITC labeled with PECAM-1 in the retinas perfused with FITC-dextran. Dextran was perfused into the stalk cells (arrowheads) in both Lif+/+ and Lif–/– mice. (W and X) Triple IHC for PECAM-1, Mac-1, and desmin in P4 retinas. Scale bars: 50 μm. *P < 0.03 versus Lif+/+.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts